Trial Profile
An Open-label, Multicenter, Multiple-dose, Phase III Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary)
- Indications Postherpetic neuralgia
- Focus Adverse reactions
- Sponsors Grunenthal
- 12 Dec 2018 New trial record